JACOBUS 25 102 (Dapsone 25 mg)

Pill imprint JACOBUS 25 102 has been identified as Dapsone 25 mg.

Dapsone is used in the treatment of dermatitis herpetiformis; pneumocystis pneumonia; bullous pemphigoid; leukocytoclastic vasculitis; leprosy, tuberculoid (and more), and belongs to the drug class leprostatics. Risk cannot be ruled out during pregnancy. Dapsone 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for JACOBUS 25 102

Dapsone 25 mg JACOBUS 25 102 Front
Dapsone 25 mg JACOBUS 25 102 Back
Dapsone 25 mg JACOBUS 25 102
Dapsone
Imprint:
JACOBUS
25 102
Strength:
25 mg
Color:
White
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Leprostatics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Jacobus Pharmaceutical Company
National Drug Code (NDC):
49938-0102
Inactive Ingredients:
silicon dioxide
magnesium stearate
microcrystalline cellulose
corn starch
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-2817 Physicians Total Care Inc (repackager)
55289-0188 PDRX Pharmaceuticals Inc (repackager)
68258-9091 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)